Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$111M |
| 2 |
Ferguson
FERG
|
+$106M |
| 3 |
Apple
AAPL
|
+$103M |
| 4 |
Amazon
AMZN
|
+$103M |
| 5 |
Tesla
TSLA
|
+$75.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TIF
Tiffany & Co.
TIF
|
+$96.7M |
| 2 |
DuPont de Nemours
DD
|
+$51.9M |
| 3 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$43.4M |
| 4 |
AvalonBay Communities
AVB
|
+$36.1M |
| 5 |
Equity Residential
EQR
|
+$21.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.7% |
| 2 | Healthcare | 14.14% |
| 3 | Consumer Discretionary | 13.71% |
| 4 | Communication Services | 10.92% |
| 5 | Industrials | 9.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Mativ Holdings
MATV
$690M
| $3.51M | ﹤0.01% |
71,600
+900
| +1% | +$39.7K |
|
|
HUYA
1677
Huya Inc
HUYA
$547M
| $3.49M | ﹤0.01% |
179,348
+104,048
| +138% | +$2.61M |
|
1678
Primoris Services
PRIM
$4.39B
| $3.49M | ﹤0.01% |
105,400
+2,200
| +2% | +$72.4K |
|
|
IMGN
1679
DELISTED
Immunogen Inc
IMGN
| $3.47M | ﹤0.01% |
428,400
+33,100
| +8% | +$270K |
|
1680
Newmark Group
NMRK
$2.68B
| $3.46M | ﹤0.01% |
345,307
+6,000
| +2% | +$53.8K |
|
|
HSKA
1681
DELISTED
Heska Corp
HSKA
| $3.45M | ﹤0.01% |
20,500
+300
| +1% | +$53.2K |
|
|
LGF.B
1682
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $3.45M | ﹤0.01% |
267,594
+4,600
| +2% | +$60.6K |
|
|
ILPT
1683
Industrial Logistics Properties Trust
ILPT
$605M
| $3.45M | ﹤0.01% |
149,147
+1,400
| +0.9% | +$31.4K |
|
1684
Levi Strauss
LEVI
$8.64B
| $3.45M | ﹤0.01% |
144,200
+4,600
| +3% | +$103K |
|
|
SGMO
1685
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $3.44M | ﹤0.01% |
274,660
+3,300
| +1% | +$44.5K |
|
1686
Workhorse Group
WKHS
$33.7M
| $3.41M | ﹤0.01% |
83
+5
| +6% | +$359K |
|
|
WW
1687
DELISTED
WW International
WW
| $3.41M | ﹤0.01% |
108,900
+1,300
| +1% | +$37.4K |
|
|
PGTI
1688
DELISTED
PGT, Inc.
PGTI
| $3.4M | ﹤0.01% |
134,800
+1,200
| +0.9% | +$28.2K |
|
|
WDR
1689
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $3.4M | ﹤0.01% |
135,700
-4,300
| -3% | -$108K |
|
1690
Cytokinetics
CYTK
$10.5B
| $3.38M | ﹤0.01% |
145,500
+2,000
| +1% | +$42.7K |
|
|
CSGS
1691
DELISTED
CSG Systems International
CSGS
| $3.38M | ﹤0.01% |
75,300
+400
| +0.5% | +$18.4K |
|
1692
Oxford Industries
OXM
$538M
| $3.37M | ﹤0.01% |
38,600
+600
| +2% | +$46.1K |
|
1693
TTM Technologies
TTMI
$14.5B
| $3.36M | ﹤0.01% |
231,700
+2,900
| +1% | +$41.1K |
|
1694
Ichor Holdings
ICHR
$2.59B
| $3.36M | ﹤0.01% |
62,400
+900
| +1% | +$38.3K |
|
1695
FB Financial Corp
FBK
$3.1B
| $3.36M | ﹤0.01% |
75,483
+1,700
| +2% | +$69.9K |
|
|
CATM
1696
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $3.35M | ﹤0.01% |
86,400
+700
| +0.8% | +$27.2K |
|
1697
Enterprise Financial Services Corp
EFSC
$2.41B
| $3.35M | ﹤0.01% |
67,764
+11,500
| +20% | +$484K |
|
|
VBTX
1698
DELISTED
Veritex Holdings
VBTX
| $3.34M | ﹤0.01% |
102,117
+1,100
| +1% | +$32.4K |
|
|
KRTX
1699
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $3.32M | ﹤0.01% |
27,600
+500
| +2% | +$56.6K |
|
1700
Coca-Cola Consolidated
COKE
$12.6B
| $3.31M | ﹤0.01% |
114,650
+2,000
| +2% | +$55K |
|
Similar funds
Swiss National Bank's Q1 2021 Portfolio in Review
As of Q1 2021, Swiss National Bank held 2,502 positions worth $150B, up 6.6% from $141B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q1 2021: portfolio turnover was 1.3%. Swiss National Bank opened 12 new positions and exited 20, leaving the 2,502-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q1 2021 buy was Ferguson: 872,392 shares worth $104M.
- Swiss National Bank added most to Microsoft in Q1 2021, an estimated $111M increase.
- Swiss National Bank's biggest Q1 2021 reduction was DuPont de Nemours, cutting an estimated $51.9M.
- Swiss National Bank fully exited Tiffany & Co. in Q1 2021, selling an estimated $96.7M.
- Swiss National Bank's ten largest holdings make up 23% of its $150B portfolio in Q1 2021.
- Swiss National Bank opened 12 new positions and closed 20 in Q1 2021.
- Swiss National Bank's portfolio value rose 6.6% quarter-over-quarter to $150B.
Based on Swiss National Bank's 13F filing for Q1 2021, filed 7 May 2021.